Business Description
Pharnext SA
ISIN : FR001400N1P4
Compare
Compare
Traded in other countries / regions
ALPHA.FranceP0X.GermanyPNEXF.USA IPO Date
2019-04-09Description
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -6.1 | |||||
| Debt-to-Equity | -0.81 | |||||
| Debt-to-EBITDA | -0.84 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -27.57 | |||||
| Beneish M-Score | -17.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -84.2 | |||||
| 3-Year EBITDA Growth Rate | -22.6 | |||||
| 3-Year EPS without NRI Growth Rate | 97.3 | |||||
| 3-Year FCF Growth Rate | -5.4 | |||||
| 3-Year Book Growth Rate | -65.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 100 | |||||
| 14-Day RSI | 100 | |||||
| 12-1 Month Momentum % | 999900 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.37 | |||||
| Quick Ratio | 0.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2215.87 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -17527.33 | |||||
| Net Margin % | -21036 | |||||
| FCF Margin % | -15682.82 | |||||
| ROA % | -394.52 | |||||
| ROIC % | -264.17 | |||||
| ROC (Joel Greenblatt) % | -4946.58 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.82 | |||||
| EV-to-EBITDA | -0.84 | |||||
| EV-to-Forward-EBITDA | -0.7 | |||||
| EV-to-Revenue | 166.85 | |||||
| EV-to-Forward-Revenue | 8.07 | |||||
| EV-to-FCF | -1.05 | |||||
| Earnings Yield (Greenblatt) % | -121.95 | |||||
| FCF Yield % | -22993.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PNEXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharnext SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.163 | ||
| EPS (TTM) ($) | -99999999.999 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 525.475694 | ||
| 20-Day SMA ($) | 250000000000 | ||
| 12-1 Month Momentum % | 999900 | ||
| 52-Week Range ($) | 25000000 - 250000000000 | ||
| Shares Outstanding (Mil) | 0.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharnext SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharnext SA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharnext SA Frequently Asked Questions
What is Pharnext SA(PNEXF)'s stock price today?
The current price of PNEXF is $250000000000.00. The 52 week high of PNEXF is $250000000000.00 and 52 week low is $25000000.00.
When is next earnings date of Pharnext SA(PNEXF)?
The next earnings date of Pharnext SA(PNEXF) is .
Does Pharnext SA(PNEXF) pay dividends? If so, how much?
Pharnext SA(PNEXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers